Top

Quality of Life Research

Gepubliceerd in:

22-07-2021

Cross-cultural adaptation of the SWAL-QOL and the Sydney Swallow Questionnaire (SSQ) into French-Canadian and preliminary assessment for their use in an oculopharyngeal muscular dystrophy (OPMD) population

Auteurs: Claudia Côté, Julie Fortin, Bernard Brais, Sarah Youssof, Cynthia Gagnon

Gepubliceerd in: Quality of Life Research | Uitgave 1/2022

Abstract

Purpose

Patient-reported outcomes (PRO) assessing dysphagia are an essential component of clinical trials to consider how patients feel and function in response to treatments. The selected PRO needs to be translated in several languages using a systematic process ensuring its validity and equivalence for use in multicenter clinical trials. The main objectives were to translate the SWAL-QOL and the Sydney Swallow Questionnaire (SSQ) into French Canadian (SWAL-QOL-FC and SSQ-FC) and to assess their appropriateness for patients with oculopharyngeal muscular dystrophy (OPMD).

Methods

A forward- and back-translation process was followed including independent mother-tongue translators followed by committee review. Known-groups validity was assessed by comparing scores of OPMD French-Canadian participants (n = 21) known to differ in dysphagia severity according to the 80-ml drinking test score. A Mann–Whitney test was used to compare the mean scores. Cognitive interviews were conducted later on to ensure a posteriori cultural equivalence among French-Canadian participants (n = 28).

Results

Evidences of adequate known-groups validity was shown for the SSQ-FC. Only two domains out of 10 of the SWAL-QOL-FC (burden and eating duration) showed adequate known-groups validity. In addition, the difference in the mean composite score was not significant. Several conceptual equivalence issues were found in both questionnaires as a result of the cognitive interviews.

Conclusion

This study provided evidence that the SSQ-FC presents better validity than the SWAL-QOL-FC in a small sample size of OPMD participants. The findings of the cognitive interviews suggest the need to develop an OPMD-specific questionnaire to capture better the whole spectrum of disease severity.

vorige artikel Development of a physical function outcome measure to harmonize comparisons between three Asian adult populations

volgende artikel Comparison of patient- and clinician-reported outcome measures in lower back rehabilitation: introducing a new integrated performance measure (t2D)

Alleen toegankelijk voor geautoriseerde gebruikers

Becher, M. W., et al. (2001). Oculopharyngeal muscular dystrophy in Hispanic New Mexicans. JAMA, 286(19), 2437–2440.PubMedCrossRef

Barbeau, A. (1966). The syndrome of hereditary late onset ptosis and dysphagia in French Canada. In E. Kuhn (Ed.), Progressive Muskeldystrophie Myotonie · Myasthenie (pp. 102–109). Berlin: Springer-Verlag.CrossRef

Blumen, S. C., et al. (1993). Clinical features of oculopharyngeal muscular dystrophy among Bukhara Jews. Neuromuscular Disorders, 3(5–6), 575–577.PubMedCrossRef

Duranceau, A., Forand, M. D., & Fauteux, J. P. (1980). Surgery in oculopharyngeal muscular dystrophy. American Journal of Surgery, 139(1), 33–39.PubMedCrossRef

Castell, J. A., et al. (1995). Manometric characteristics of the pharynx, upper esophageal sphincter, esophagus, and lower esophageal sphincter in patients with oculopharyngeal muscular dystrophy. Dysphagia, 10(1), 22–26.PubMedCrossRef

Brisson, J. D., et al. (2020). A study of impairments in oculopharyngeal muscular dystrophy. Muscle & Nerve, 62(2), 201–207.CrossRef

Speyer, R. (2013). Oropharyngeal dysphagia: Screening and assessment. Otolaryngologic Clinics of North America, 46(6), 989–1008.PubMedCrossRef

U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006). Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims: Draft guidance. Health and Quality of Life Outcomes, 4, 79.

Timmerman, A. A., et al. (2014). Psychometric characteristics of health-related quality-of-Life questionnaires in oropharyngeal dysphagia. Dysphagia, 29(2), 183–198.PubMedCrossRef

10.

Orlandoni, N., & Peladic, N. J. (2016). Health-related quality of life and functional health status questionnaires in oropharyngeal dysphagia. The Journal of Aging Research and Clinical Practice, 5(1), 31–37.

11.

Côté, C., et al. (2019). The requirement for a disease-specific patient-reported outcome measure of dysphagia in oculopharyngeal muscular dystrophy. Muscle & Nerve, 59(4), 445–450.CrossRef

12.

Périé, S., et al. (2014). Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: A phase I/IIa clinical study. Molecular Therapy, 22(1), 219–225.PubMedCrossRef

13.

Argov, Z., et al. (2016). Intravenous Trehalose Improves Dysphagia and Muscle Function in Oculopharyngeal Muscular Dystrophy (OPMD): Preliminary Results of 24 Weeks Open Label Phase 2 Trial (S28.004). Neurology, 86(16 Supplement), S28.004.

14.

McHorney, C. A., et al. (2000). The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults : I. Conceptual foundation and item development. Dysphagia, 15(3), 115–121.PubMed

15.

McHorney, C. A. (2002). The potential clinical value of quality-of-life information response to Martin. Medical Care, 40(6 Suppl), 56–62.

16.

Plowman-Prine, E. K., et al. (2009). The relationship between quality of life and swallowing in Parkinson’s disease. Movement Disorders, 24(9), 1352–1358.PubMedPubMedCentralCrossRef

17.

McHorney, C. A., et al. (2002). The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults : III. Documentation of reliability and validity. Dysphagia, 17(2), 97–114.PubMed

18.

Rinkel, R. N., et al. (2009). The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating swallowing problems experienced by patients with oral and oropharyngeal cancer. Oral Oncology, 45(8), e67-71.PubMedCrossRef

19.

Rinkel, R. N., et al. (2015). Validity of patient-reported swallowing and speech outcomes in relation to objectively measured oral function among patients treated for oral or oropharyngeal cancer. Dysphagia, 30(2), 196–204.PubMedCrossRef

20.

Rinkel, R. N., et al. (2014). Patient-reported symptom questionnaires in laryngeal cancer: Voice, speech and swallowing. Oral Oncology, 50(8), 759–764.PubMedCrossRef

21.

Tabor, L., et al. (2016). Defining swallowing-related quality of life profiles in individuals with amyotrophic lateral sclerosis. Dysphagia, 31(3), 376–382.PubMedPubMedCentralCrossRef

22.

Youssof, S., et al. (2016). Dysphagia-related Quality of Life in oculopharyngeal muscular dystrophy: Psychometric properties of the SWAL-QOL instrument. Muscle & Nerve, 56(1), 28–35.CrossRef

23.

Dwivedi, R. C., et al. (2010). Validation of the Sydney Swallow Questionnaire (SSQ) in a cohort of head and neck cancer patients. Oral Oncology, 46(4), e10–e14.PubMedCrossRef

24.

Wallace, K. L., Middleton, S., & Cook, I. J. (2000). Development and validation of a self-report symptom inventory to assess the severity of oral-pharyngeal dysphagia. Gastroenterology, 118(4), 678–687.PubMedCrossRef

25.

Manjaly, J., et al. (2011). Cricopharyngeal dilatation for the long-term treatment of dysphagia in oculopharyngeal muscular dystrophy. Dysphagia, 27, 216–220.PubMedCrossRef

26.

Khaldoun, E., Woisard, V., & Verin, E. (2009). Validation in French of the SWAL-QOL scale in patients with oropharyngeal dysphagia. Gastroenterologie Clinique et Biologique, 33(3), 167–171.PubMedCrossRef

27.

Audag, N., et al. (2019). Validation and reliability of the French version of the sydney swallow questionnaire. Dysphagia, 34(4), 556–566.PubMedCrossRef

28.

Epstein, J., Santo, R. M., & Guillemin, F. (2015). A review of guidelines for cross-cultural adaptation of questionnaires could not bring out a consensus. Journal of Clinical Epidemiology, 68(4), 435–441.PubMedCrossRef

29.

Wild, D., et al. (2005). Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR task force for translation and cultural adaptation. Value Health, 8(2), 94–104.PubMedCrossRef

30.

Mokkink, L. B., et al. (2010). Inter-rater agreement and reliability of the COSMIN (COnsensus-based Standards for the selection of health status Measurement Instruments) checklist. BMC Medical Research Methodology, 10, 82.PubMedPubMedCentralCrossRef

31.

Bouchard, J. P., et al. (1997). Recent studies on oculopharyngeal muscular dystrophy in Québec. Neuromuscular Disorders: NMD, 7(Suppl 1), S22–S29.PubMedCrossRef

32.

Bouchard, J. P., et al. (1992). A simple test for the detection of the dysphagia in members of families with oculopharyngeal muscular dystrophy (OPMD). The Canadian Journal of Neurological Sciences. Le Journal Canadien des Sciences Neurologiques, 19, 296–297.

33.

Willis, G. B. (2005). Cognitive Interviewing: A tool for Improving Questionnaire Design. London: SAGE Publications.CrossRef

34.

Herdman, M., Fox-Rushby, J., & Badia, X. (1998). A model of equivalence in the cultural adaptation of HRQoL instruments: The universalist approach. Quality of Life Research, 7(4), 323–335.PubMedCrossRef

35.

Wuensch, K.L. Nonparametric Effect Size Estimators. 2015. Available from: http://core.ecu.edu/psyc/wuenschk/docs30/Nonparametric-EffectSize.pdf.

36.

Kurtz, N. S., et al. (2019). Patient-reported disease burden in oculopharyngeal muscular dystrophy. Muscle and Nerve, 60(6), 724–731.PubMedCrossRef

37.

Hilgers, R. D., et al. (2016). Design and analysis of clinical trials for small rare disease populations. Journal of Rare Diseases Research & Treatment, 1(3), 53–60.CrossRef

38.

Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989). Effect sizes for interpreting changes in health status. Medical Care, 27(3 Suppl), S178–S189.PubMedCrossRef

39.

Szczesniak, M. M., et al. (2014). The normative range for and age and gender effects on the Sydney Swallow Questionnaire (SSQ). Dysphagia, 29(5), 535–538.PubMedCrossRef

40.

Duranceau, A. (2013). Disorders of the Pharyngoesophageal Junction. In C. J. Yeo (Ed.), Shackelford’s surgery of the alimentary tract (7th ed.). Elsevier/Saunders: Philadelphia PA.

Titel: Cross-cultural adaptation of the SWAL-QOL and the Sydney Swallow Questionnaire (SSQ) into French-Canadian and preliminary assessment for their use in an oculopharyngeal muscular dystrophy (OPMD) population
Auteurs: Claudia Côté
Julie Fortin
Bernard Brais
Sarah Youssof
Cynthia Gagnon
Publicatiedatum: 22-07-2021
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 1/2022
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-021-02915-0

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2022

A two-step, test-guided Mokken scale analysis, for nonclustered and clustered data

Comparison of patient- and clinician-reported outcome measures in lower back rehabilitation: introducing a new integrated performance measure (t2D)

Correction to: Patients’ and parents’ perspective on the implementation of Patient Reported Outcome Measures in pediatric clinical practice using the KLIK PROM portal

Developing and testing a cognitive bolt-on for the EQ-5D-Y (Youth)

Development of a physical function outcome measure to harmonize comparisons between three Asian adult populations

Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic